Phase I study of Carzelesin (U-80,244) given (4-weekly) by intravenous bolus schedule.
Awada A, Punt CJ, Piccart MJ, Van Tellingen O, Van Manen L, Kerger J, Groot Y, Wanders J, Verweij J, Wagener DJ.
Awada A, et al. Among authors: wanders j.
Br J Cancer. 1999 Mar;79(9-10):1454-61. doi: 10.1038/sj.bjc.6690232.
Br J Cancer. 1999.
PMID: 10188890
Free PMC article.
Clinical Trial.